Vivus Inc. said its effort to win regulatory approval for weight-loss pill Qnexa may be helped by a study showing little risk of birth defects in children of women who took one of the medicine’s ingredients.
A Roche Holding AG experimental drug called MetMab, used with another medicine, extended the lives of lung-cancer patients whose tumors had high levels of a protein known to trigger the disease and help it spread, a study found.
Alkermes Inc. , maker of the Vivitrol addiction therapy, agreed to buy Elan Drug Technologies , a unit of Elan Corp. that works with pharmaceutical companies to make products easier to take, in a deal valued at $960 million.
A drug sold by Amgen Inc. and Johnson & Johnson for people with anemia didn’t reduce heart damage in patients who’d experienced heart attacks and may increase the chances of recurrence or death, a study found.
Amgen Inc. , the world’s largest biotechnology company, will pay its first dividend next quarter even as research spending continues to absorb as much as 20 percent of revenue, Chief Executive Officer Kevin Sharer said.
A device developed by PLC Medical Systems Inc., the maker of equipment used in cardiac procedures, reduced the number of patients who developed kidney damage from a thick dye used to help peer into patient’s hearts and veins.
Exelixis Inc. is working with Goldman Sachs Group Inc. to prepare for potential takeover offers after its experimental drug helped prostate-cancer patients in a study, said people with knowledge of the matter.